利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

10 条记录 (耗时 0.051 秒)

    G protein coupled receptor protein and use thereof
    1.
    发明授权
    G protein coupled receptor protein and use thereof 有权
    G蛋白偶联受体蛋白及其用途

    公开(公告)号：US09034327B2

    公开(公告)日：2015-05-19

    申请号：US13322304

    申请日：2009-09-07

    申请人： Kyung Sook Chung ,  Mi Sun Won ,  Ji Won Ahn ,  Jeong Hae Choi ,  Hyang Sook Yoo ,  Young Il Yeom ,  Eun Young Song ,  Hee Gu Lee ,  Jae Hun Cheong ,  Chang Mo Kang

    发明人： Kyung Sook Chung ,  Mi Sun Won ,  Ji Won Ahn ,  Jeong Hae Choi ,  Hyang Sook Yoo ,  Young Il Yeom ,  Eun Young Song ,  Hee Gu Lee ,  Jae Hun Cheong ,  Chang Mo Kang

    IPC分类号： G01N33/53 ,  C07K14/705 ,  G01N33/50

    CPC分类号： C07K14/705 ,  G01N33/5041

    摘要： Disclosed are novel GPCR (G Protein Coupled Receptor) proteins and genes encoding the same. Also provided is the use of the proteins and the genes. Particularly, contemplated are a novel GPCR (G Protein Coupled Receptor) polypeptide, a polynucleotide coding for the same, a recombinant vector carrying the polynucleotide or a fragment thereof, host cells transformed with the vector, a transgenic animal infected with the vector. Also, a composition for detecting a cancer marker, comprising an agent capable of measuring the expression level of mRNA or protein of the GPCR polynucleotide, a kit for the diagnosis of cancer, comprising the composition, and a method for detecting the GPCR polypeptide and a gene encoding the polypeptide are provided. Further, a composition for the treatment and prevention of cancer, comprising an oligonucleotide inhibiting the expression of a gene encoding the GPCR polypeptide or an antibody against the GPCR protein, and a method for screening a modulator of the GPCR protein or a cancer therapeutic agent are provided.

    摘要翻译： 公开了新型GPCR（G蛋白偶联受体）蛋白和编码其的基因。 还提供了蛋白质和基因的使用。 特别地，考虑了新型GPCR（G蛋白偶联受体）多肽，编码它的多核苷酸，携带多核苷酸或其片段的重组载体，用该载体转化的宿主细胞，用载体感染的转基因动物。 另外，含有能够测定GPCR多核苷酸的mRNA或蛋白质的表达量的试剂，癌症诊断用试剂盒，含有该组合物的检测癌标记物的组合物，以及检测GPCR多肽的方法和 提供编码多肽的基因。 此外，用于治疗和预防癌症的组合物包含抑制GPCR多肽或编码GPCR蛋白的抗体表达的寡核苷酸以及筛选GPCR蛋白或癌症治疗剂的调节剂的方法， 提供。

    NOVEL G PROTEIN COUPLED RECEPTOR PROTEIN AND USE THEREOF
    2.
    发明申请
    NOVEL G PROTEIN COUPLED RECEPTOR PROTEIN AND USE THEREOF 有权
    新型G蛋白偶联受体蛋白及其用途

    公开(公告)号：US20120141488A1

    公开(公告)日：2012-06-07

    申请号：US13322304

    申请日：2009-09-07

    申请人： Kyung Sook Chung ,  Mi Sun Won ,  Ji Won Ahn ,  Jeong Hae Choi ,  Hyang Sook Yoo ,  Young Il Yeom ,  Eun Young Song ,  Hae Gu Lee ,  Jae Hun Cheong ,  Chang Mo Kang

    发明人： Kyung Sook Chung ,  Mi Sun Won ,  Ji Won Ahn ,  Jeong Hae Choi ,  Hyang Sook Yoo ,  Young Il Yeom ,  Eun Young Song ,  Hae Gu Lee ,  Jae Hun Cheong ,  Chang Mo Kang

    IPC分类号： A61K39/395 ,  G01N33/53 ,  G01N33/566 ,  G01N27/447 ,  A61K31/7088 ,  A61P35/00 ,  A61P35/04 ,  C12Q1/68 ,  C12Q1/02

    CPC分类号： C07K14/705 ,  G01N33/5041

    摘要： Disclosed are novel GPCR (G Protein Coupled Receptor) proteins and genes encoding the same. Also provided is the use of the proteins and the genes. Particularly, contemplated are a novel GPCR (G Protein Coupled Receptor) polypeptide, a polynucleotide coding for the same, a recombinant vector carrying the polynucleotide or a fragment thereof, host cells transformed with the vector, a transgenic animal infected with the vector. Also, a composition for detecting a cancer marker, comprising an agent capable of measuring the expression level of mRNA or protein of the GPCR polynucleotide, a kit for the diagnosis of cancer, comprising the composition, and a method for detecting the GPCR polypeptide and a gene encoding the polypeptide are provided. Further, a composition for the treatment and prevention of cancer, comprising an oligonucleotide inhibiting the expression of a gene encoding the GPCR polypeptide or an antibody against the GPCR protein, and a method for screening a modulator of the GPCR protein or a cancer therapeutic agent are provided.

    摘要翻译： 公开了新型GPCR（G蛋白偶联受体）蛋白和编码其的基因。 还提供了蛋白质和基因的使用。 特别地，考虑了新型GPCR（G蛋白偶联受体）多肽，编码它的多核苷酸，携带多核苷酸或其片段的重组载体，用该载体转化的宿主细胞，用载体感染的转基因动物。 另外，含有能够测定GPCR多核苷酸的mRNA或蛋白质的表达量的试剂，癌症诊断用试剂盒，含有该组合物的检测癌标记物的组合物，以及检测GPCR多肽的方法和 提供编码多肽的基因。 此外，用于治疗和预防癌症的组合物包含抑制GPCR多肽或编码GPCR蛋白的抗体表达的寡核苷酸以及筛选GPCR蛋白或癌症治疗剂的调节剂的方法， 提供。

    Marker comprising anti-CK8/18 complex autoantibody and its use for diagnosing cancer
    6.
    发明授权
    Marker comprising anti-CK8/18 complex autoantibody and its use for diagnosing cancer 有权
    包括抗CK8 / 18复合自身抗体及其用于诊断癌症的标记物

    公开(公告)号：US09234893B2

    公开(公告)日：2016-01-12

    申请号：US14000221

    申请日：2012-02-20

    申请人： Eun Wie Cho ,  Chang Gyu Heo ,  Jeong Heon Ko ,  Mi Kyung Woo ,  Hyang Sook Yoo ,  Hai Min Hwang

    发明人： Eun Wie Cho ,  Chang Gyu Heo ,  Jeong Heon Ko ,  Mi Kyung Woo ,  Hyang Sook Yoo ,  Hai Min Hwang

    IPC分类号： C07K16/18 ,  G01N33/574 ,  C07K7/06 ,  C07K16/30

    CPC分类号： G01N33/574 ,  C07K7/06 ,  C07K16/18 ,  C07K16/30 ,  C07K2317/32 ,  C07K2317/34 ,  G01N33/57415 ,  G01N2333/4742

    摘要： The present invention relates to a cytokeratin 8/18 complex-specific autoantibody or a fragment comprising an antigen-binding site (paratope) thereof, the use thereof in the diagnosis of breast cancer, a polypeptide having an amino acid sequence of an epitope specifically binding to the autoantibody, a composition for diagnosing breast cancer comprising an agent capable of measuring an expression level of the autoantibody or the fragment comprising an antigen-binding site thereof, a hybridoma cell line producing the autoantibody, and a kit for diagnosing breast cancer comprising the composition of the present invention. Further, the present invention relates to a method for diagnosing breast cancer, comprising the step of detecting the cytokeratin 8/18 complex-specific autoantibody or the fragment comprising the antigen-binding site thereof using the composition of the present invention, and a method for screening a therapeutic agent for breast cancer using the autoantibody.

    摘要翻译： 本发明涉及细胞角蛋白8/18复合物特异性自身抗体或包含其抗原结合位点（其相互作用）的片段，其在乳腺癌诊断中的应用，具有表位特异性结合的表位氨基酸序列的多肽 涉及自身抗体的用于诊断乳腺癌的组合物，其包含能够测量自身抗体表达水平的试剂或包含其抗原结合位点的片段，产生该自身抗体的杂交瘤细胞系和用于诊断乳腺癌的试剂盒， 本发明的组合物。 此外，本发明涉及一种诊断乳腺癌的方法，包括使用本发明的组合物检测细胞角蛋白8/18复合物特异性自身抗体或包含其抗原结合位点的片段的方法， 使用自身抗体筛选乳腺癌的治疗剂。

    MARKER COMPRISING ANTI-CK8/18 COMPLEX AUTOANTIBODY AND ITS USE FOR DIAGNOSING CANCER
    8.
    发明申请
    MARKER COMPRISING ANTI-CK8/18 COMPLEX AUTOANTIBODY AND ITS USE FOR DIAGNOSING CANCER 有权
    包含抗CK8 / 18复合自身抗体的标记及其用于诊断癌症的用途

    公开(公告)号：US20140093892A1

    公开(公告)日：2014-04-03

    申请号：US14000221

    申请日：2012-02-20

    申请人： Eun Wie Cho ,  Chang Gyu Heo ,  Jeong Heon Ko ,  Mi Kyung Woo ,  Hyang Sook Yoo ,  Hai Min Hwang

    发明人： Eun Wie Cho ,  Chang Gyu Heo ,  Jeong Heon Ko ,  Mi Kyung Woo ,  Hyang Sook Yoo ,  Hai Min Hwang

    IPC分类号： G01N33/574 ,  C07K7/06 ,  C07K16/18

    CPC分类号： G01N33/574 ,  C07K7/06 ,  C07K16/18 ,  C07K16/30 ,  C07K2317/32 ,  C07K2317/34 ,  G01N33/57415 ,  G01N2333/4742

    摘要： The present invention relates to a cytokeratin 8/18 complex-specific autoantibody or a fragment comprising an antigen-binding site (paratope) thereof, the use thereof in the diagnosis of breast cancer, a polypeptide having an amino acid sequence of an epitope specifically binding to the autoantibody, a composition for diagnosing breast cancer comprising an agent capable of measuring an expression level of the autoantibody or the fragment comprising an antigen-binding site thereof, a hybridoma cell line producing the autoantibody, and a kit for diagnosing breast cancer comprising the composition of the present invention. Further, the present invention relates to a method for diagnosing breast cancer, comprising the step of detecting the cytokeratin 8/18 complex-specific autoantibody or the fragment comprising the antigen-binding site thereof using the composition of the present invention, and a method for screening a therapeutic agent for breast cancer using the autoantibody.

    摘要翻译： 本发明涉及细胞角蛋白8/18复合物特异性自身抗体或包含其抗原结合位点（其相互作用）的片段，其在乳腺癌诊断中的应用，具有表位特异性结合的表位氨基酸序列的多肽 涉及自身抗体的用于诊断乳腺癌的组合物，其包含能够测量自身抗体表达水平的试剂或包含其抗原结合位点的片段，产生该自身抗体的杂交瘤细胞系和用于诊断乳腺癌的试剂盒， 本发明的组合物。 此外，本发明涉及一种诊断乳腺癌的方法，包括使用本发明的组合物检测细胞角蛋白8/18复合物特异性自身抗体或包含其抗原结合位点的片段的方法， 使用自身抗体筛选乳腺癌的治疗剂。

    Diagnostic marker for hepatocellular carcinoma comprising anti-FASN autoantibodies and a diagnostic composition for hepatocellular carcinoma comprising antigens thereof
    9.
    发明授权
    Diagnostic marker for hepatocellular carcinoma comprising anti-FASN autoantibodies and a diagnostic composition for hepatocellular carcinoma comprising antigens thereof 有权
    包括抗FASN自身抗体的肝细胞癌的诊断标记和包含其抗原的肝细胞癌诊断组合物

    公开(公告)号：US08658769B2

    公开(公告)日：2014-02-25

    申请号：US13501426

    申请日：2010-10-01

    申请人： Eun Wie Cho ,  Chang Kyu Heo ,  Mi Kyung Woo ,  Hai Min Hwang ,  Hyang Sook Yoo ,  Jeong Heun Ko

    发明人： Eun Wie Cho ,  Chang Kyu Heo ,  Mi Kyung Woo ,  Hai Min Hwang ,  Hyang Sook Yoo ,  Jeong Heun Ko

    IPC分类号： C07K16/00

    CPC分类号： C07K16/40 ,  C07K2317/34 ,  G01N33/57438

    摘要： The present invention relates to an autoantibody specifically recognizing the epitope sequence of FASN (fatty acid synthase), more particularly, to the autoantibody or a fragment comprising an antigen-binding site thereof, a diagnostic composition for hepatocellular carcinoma comprising an agent capable of assessing the expression level of the autoantibody, a hybridoma cell line producing the autoantibody, a diagnostic kit for hepatocellular carcinoma comprising the composition, a method for detecting the autoantibody of hepatocellular carcinoma patient using the composition, and a method for screening a therapeutic agent for hepatocellular carcinoma by administering candidate materials for hepatocellular carcinoma treatment to confirm a reduction in the expression level of autoantibody.

    摘要翻译： 本发明涉及特异性识别FASN（脂肪酸合成酶）的表位序列的自身抗体，更具体地，涉及自身抗体或其抗原结合位点的片段，包括能够评估 自身抗体的表达水平，产生自身抗体的杂交瘤细胞系，包含该组合物的肝细胞癌的诊断试剂盒，使用该组合物检测肝细胞癌患者的自身抗体的方法，以及用于筛选肝细胞癌治疗剂的方法 管理候选材料进行肝细胞癌治疗以确认自身抗体表达水平的降低。